Table 4.
Variables | Number of studies | n* (%) |
---|---|---|
Atrial fibrillation | 1 | 1 (3.4) |
Hyperlipidemia | 1 | 1 (3.4) |
Hypertension | 7 | 17 (58.6) |
Diabetes mellitus | 7 | 14 (48.3) |
Rheumatoid arthritis | 1 | 1 (3.4) |
Interstitial lung disease | 1 | 1 (3.4) |
Chronic obstructive pulmonary disease | 1 | 1 (3.4) |
Haemodialysis | 4 | 5 (17.2) |
Hypothyroidism | 1 | 1 (3.4) |
Dyslipidemia | 2 | 2 (6.9) |
Myocardial infarction | 1 | 1 (3.4) |
Gastroesophageal reflux disease | 1 | 1 (3.4) |
Chronic kidney disease | 3 | 3 (10.3) |
Congestive heart failure | 1 | 1 (3.4) |
Coronary artery disease | 1 | 1 (3.4) |
n, number of co-infected patients with any variables.